Impact BioMedical Inc./$IBO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Impact BioMedical Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Ticker
$IBO
Sector
Primary listing
AMEX
Industry
Pharmaceuticals
Headquarters
Employees
2
ISIN
US45259L2051
Website
IBO Metrics
BasicAdvanced
$5.2M
-
-$2.22
-
-
Price and volume
Market cap
$5.2M
52-week high
$6.17
52-week low
$0.37
Average daily volume
430K
Financial strength
Current ratio
0.219
Quick ratio
0.133
Total debt to equity
134.229
Interest coverage (TTM)
-3.29%
Profitability
EBITDA (TTM)
-3.63
Effective tax rate (TTM)
-0.13%
Management effectiveness
Return on assets (TTM)
-7.06%
Return on equity (TTM)
-147.03%
Valuation
Price to book
1.38
Price to tangible book (TTM)
-0.37
Price to free cash flow (TTM)
-1.183
Free cash flow yield (TTM)
-84.50%
Free cash flow per share (TTM)
-36.54%
Growth
Earnings per share change (TTM)
2,062.18%
3-year earnings per share growth (CAGR)
371.88%
IBO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Impact BioMedical Inc. stock?
Impact BioMedical Inc. (IBO) has a market cap of $5.2M as of June 20, 2025.
What is the P/E ratio for Impact BioMedical Inc. stock?
The price to earnings (P/E) ratio for Impact BioMedical Inc. (IBO) stock is 0 as of June 20, 2025.
Does Impact BioMedical Inc. stock pay dividends?
No, Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Impact BioMedical Inc. dividend payment date?
Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders.
What is the beta indicator for Impact BioMedical Inc.?
Impact BioMedical Inc. (IBO) does not currently have a Beta indicator.